Hospital
SSM Cardinal Glennon Children's Hospital
SSM Cardinal Glennon Children's Hospital was paid $52.60M by Medicaid between Jan 2018 and Dec 2024, across 178 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 23% of everything it billed.
33Billing provider infoSSM CARDINAL GLENNON CHILDREN'S HOSPITAL
SAINT LOUIS, MO 63104
SAINT LOUIS, MO 63104
33aNPI1508935891assigned 11/08/2006
33bProvider typeChildren's Hospital
28Total paid$52.60M
24GClaims440,218
24DCodes billed178
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 62,371 | $13.10M | |
| 2019 | 76,790 | $9.13M | |
| 2020 | 49,362 | $3.08M | |
| 2021 | 63,884 | $135K | |
| 2022 | 62,725 | $7.76M | |
| 2023 | 69,423 | $10.55M | |
| 2024incomplete | 55,663 | $8.84M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 23% | 88,642 | 84,885 | $11.89M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 48,783 | 47,973 | $10.69M |
| X4011 | State-specific procedure code | 15% | 38,366 | 37,816 | $7.94M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.9% | 32,885 | 32,546 | $4.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.3% | 10,497 | 10,274 | $3.30M |
| X4003 | 3.2% | 28,980 | 27,289 | $1.70M | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 4,249 | 2,251 | $910K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 18,847 | 18,243 | $906K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 10,083 | 8,275 | $596K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.1% | 16,198 | 15,834 | $579K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 3,876 | 3,790 | $570K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.1% | 122 | 117 | $565K |
166 more codes
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 286 | $518K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,852 | $505K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,606 | $489K |
| Y7506 | <1% | 637 | $425K | |
| X4006 | <1% | 129 | $421K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12,324 | $379K |
| 99285 | Emergency room visit (most serious) | <1% | 659 | $369K |
| 93325 | <1% | 1,431 | $359K | |
| 88300 | <1% | 317 | $340K | |
| 92567 | <1% | 7,016 | $337K | |
| 87081 | <1% | 3,127 | $320K | |
| 94010 | <1% | 2,467 | $286K | |
| 80053 | Comprehensive metabolic panel | <1% | 6,028 | $258K |
| 85046 | <1% | 3,073 | $213K | |
| 80069 | <1% | 1,008 | $188K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,180 | $180K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 897 | $171K |
| 92555 | <1% | 2,131 | $166K | |
| 82570 | <1% | 482 | $153K | |
| 81001 | <1% | 2,020 | $150K | |
| 90686 | <1% | 7,616 | $147K | |
| 90670 | <1% | 3,497 | $126K | |
| 0240U | <1% | 556 | $96K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,509 | $87K |
| 87420 | <1% | 430 | $84K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 619 | $74K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,327 | $72K |
| 86003 | <1% | 979 | $71K | |
| 92551 | <1% | 1,648 | $71K | |
| 90723 | <1% | 2,030 | $70K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 755 | $66K |
| 83655 | <1% | 1,727 | $65K | |
| 82728 | <1% | 1,638 | $64K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,794 | $59K |
| 85027 | <1% | 884 | $56K | |
| 72082 | <1% | 937 | $53K | |
| 90648 | <1% | 1,080 | $51K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 553 | $49K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 393 | $49K |
| G0378 | Hospital observation service, per hour | <1% | 42 | $44K |
| 83735 | <1% | 545 | $42K | |
| 84100 | <1% | 410 | $42K | |
| 92504 | <1% | 636 | $41K | |
| 64642 | <1% | 60 | $41K | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,786 | $39K |
| J3490 | Unclassified drugs | <1% | 8,983 | $39K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 57 | $37K |
| 92558 | <1% | 2,793 | $36K | |
| 83970 | <1% | 229 | $35K | |
| 92582 | <1% | 524 | $33K | |
| 90647 | <1% | 890 | $31K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 55 | $30K |
| 84156 | <1% | 86 | $29K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $28K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 68 | $28K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 136 | $26K |
| 81003 | <1% | 1,241 | $26K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 29 | $26K |
| 82785 | <1% | 562 | $25K | |
| 90680 | <1% | 514 | $24K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,959 | $24K |
| 73130 | <1% | 300 | $24K | |
| 95012 | <1% | 653 | $22K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 150 | $20K |
| 81002 | <1% | 86 | $19K | |
| 99173 | <1% | 419 | $17K | |
| 92579 | <1% | 561 | $17K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 42 | $17K |
| 90633 | <1% | 396 | $15K | |
| 93320 | <1% | 29 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,818 | $14K |
| 83540 | <1% | 260 | $12K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 323 | $11K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 25 | $10K |
| 83550 | <1% | 26 | $9K | |
| 82340 | <1% | 86 | $9K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 135 | $9K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 79 | $8K |
| 80061 | Lipid panel | <1% | 278 | $8K |
| 85018 | <1% | 2,435 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,491 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 891 | $7K |
| 87428 | <1% | 249 | $7K | |
| 76770 | <1% | 26 | $7K | |
| 90656 | <1% | 534 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 105 | $6K |
| 29065 | <1% | 58 | $5K | |
| 82248 | <1% | 210 | $5K | |
| 90681 | <1% | 99 | $5K | |
| 73100 | <1% | 185 | $5K | |
| 76820 | <1% | 14 | $5K | |
| 81025 | <1% | 26 | $5K | |
| 90685 | <1% | 274 | $5K | |
| 76825 | <1% | 13 | $5K | |
| 76827 | <1% | 13 | $5K | |
| 90677 | <1% | 443 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 118 | $4K |
| 72170 | <1% | 39 | $4K | |
| 83020 | <1% | 59 | $4K | |
| 97162 | <1% | 28 | $4K | |
| 92523 | <1% | 12 | $3K | |
| 29075 | <1% | 47 | $3K | |
| 92511 | <1% | 16 | $3K | |
| 97161 | <1% | 21 | $3K | |
| 84466 | <1% | 108 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 12 | $2K |
| 84439 | <1% | 498 | $2K | |
| 90707 | <1% | 53 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 167 | $2K |
| 90716 | <1% | 53 | $2K | |
| 95117 | <1% | 32 | $2K | |
| 90649 | <1% | 27 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,546 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 43 | $2K |
| 92552 | <1% | 13 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 35 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 518 | $1K |
| 82784 | <1% | 703 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $1K |
| 94761 | <1% | 12 | $1K | |
| 73590 | <1% | 82 | $1K | |
| 90710 | <1% | 62 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 396 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 12 | $1K |
| 96112 | <1% | 30 | $1K | |
| 87430 | <1% | 45 | $942.54 | |
| 90734 | <1% | 88 | $935.63 | |
| 90651 | <1% | 154 | $900.73 | |
| 73090 | <1% | 102 | $820.70 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $811.07 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 125 | $803.46 |
| 0072A | <1% | 131 | $760.00 | |
| 99070 | <1% | 720 | $755.32 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 92 | $697.38 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,495 | $649.00 |
| 77072 | <1% | 63 | $608.49 | |
| 86140 | <1% | 619 | $547.68 | |
| 86480 | <1% | 16 | $504.79 | |
| 87807 | <1% | 666 | $504.51 | |
| 87799 | <1% | 28 | $381.20 | |
| 85652 | <1% | 577 | $343.57 | |
| 82610 | <1% | 13 | $342.31 | |
| 83516 | <1% | 337 | $340.01 | |
| 73630 | <1% | 32 | $328.82 | |
| 93304 | <1% | 15 | $238.00 | |
| 82977 | <1% | 36 | $218.31 | |
| 73610 | <1% | 12 | $176.35 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 16 | $156.04 |
| 86162 | <1% | 32 | $153.25 | |
| 73070 | <1% | 13 | $121.85 | |
| 0071A | <1% | 144 | $120.00 | |
| 93321 | <1% | 17 | $106.70 | |
| 86780 | <1% | 16 | $85.84 | |
| 87102 | <1% | 42 | $85.35 | |
| 86038 | <1% | 17 | $80.78 | |
| 87340 | <1% | 16 | $66.96 | |
| 87206 | <1% | 57 | $54.71 | |
| 84436 | <1% | 12 | $3.43 | |
| Y7507 | 0% | 15 | $0.00 | |
| 97803 | 0% | 53 | $0.00 | |
| 36416 | 0% | 13 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 16 | $0.00 |
| 94760 | 0% | 36 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBURGHART, STEVEN (PRESIDENT)
Parent organizationSSM HEALTH CARE CORPORATION